Found 6 matching trials
Safety and Tolerability Study of Voreloxin and Cytarabine Combination in Acute Myeloid Leukemia in Humans PHASE1 This study will evaluate the safety and tolerability of voreloxin (vosaroxi...
Show More Location
HealthOne Presbyterian/St. Luke's Medical Center
Learn More & Join Trial
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory AML PHASE3 This study compared treatment groups of patients treated with vosaroxin and...
Show More Location
Moores UCSD Cancer Center
Learn More & Join Trial
Trial to Test the Effects of Adding 1 of 2 New Treatment Agents to Commonly Used Chemotherapy Combinations PHASE2 The AML18 Trial will evaluate several relevant therapeutic questions in Acu...
Show More Location
Aalborg University Hospital
Learn More & Join Trial
Study to Improve OS in 18 to 60 Year-old Patients, Comparing Daunorubicin Versus High Dose Idarubicin Induction Regimens, High Dose Versus Intermediate Dose Cytarabine Consolidation Regimens, and Standard Versus MMF Prophylaxis of GvHD in Allografted Patients in First CR PHASE2 This open label, multicenter phase II/III study with multiple randomization...
Show More Location
CH Amiens Hôpital Sud
Learn More & Join Trial
Vosaroxin and Infusional Cytarabine in Treating Patients With Untreated Acute Myeloid Leukemia PHASE2 This phase II trial studies how well vosaroxin and cytarabine work in treat...
Show More Learn More & Join Trial
Study of Vosaroxin and Cytarabine for the Treatment of Adults 60 Years of Age or Older With Previously Untreated AML NA This is a pilot efficacy assessment clinical trial of vosaroxin and cytarab...
Show More Location
Indiana University Health Hospital
Learn More & Join Trial